Research from Queen Mary University of London has concluded that there is conclusive evidence that type 2 diabetes is associated with an increased risk for Parkinson’s disease. The same study found that there was also evidence that type 2 diabetes could contribute to faster disease progression in patients with pre-existing Parkinson’s Disease.
Treating people with already available drugs for type 2 diabetes can reduce the risk and reduce Parkinson’s progression. Screening for and early treatment of type 2 diabetes in patients with Parkinson’s Disease may be appropriate.
Previous systematic reviews and meta-analyzes have produced mixed results around the link between diabetes and Parkinson’s disease risk. This new study, published in the Movement Disorders Journal, he used meta-analysis of observational data and meta-analysis of genetic data to assess the impact of type 2 diabetes on the risk and progression of Parkinson’s disease.
This research combines results from many other studies to provide conclusive evidence that type 2 diabetes appears to affect not only Parkinson’s risk, but also Parkinson’s progression. . There are many treatment strategies for type 2 diabetes, including prevention strategies, which can be redesigned for the treatment of Parkinson’s Disease.“
Dr Alastair Noyce, Associate Research Author, Queen Mary University London
Source:
Queen Mary University of London
Magazine Reference:
Chohan, H., et al. (2021) Type 2 diabetes as a predictor of risk and progression of Parkinson’s disease. Movement Disorders. doi.org/10.1002/mds.28551.